查詢結果分析
來源資料
相關文獻
- Successful Surgical Treatment of Solitary Adrenal Metastases from Non-Small Cell Lung Cancer: Case Report
- Lung Cancer in Pregnancy: Report of Two Cases
- Ifosfamide-Based Chemotherapy for Previously Treated Lung Cancer Patients
- 化學防癌與肺癌
- 非小細胞肺癌術前輔助性化學治療的經驗
- Outcome of Patients with Lung Cancer Treated with Mechanical Ventilation for Respiratory Failure
- 不吸菸婦女肺癌研究
- Docetaxel (Taxotere)--治療乳癌與肺癌的新藥
- The Evolution of the Diagnosis and Understanding of Lung Cancer Pathology: Living Through an Epoch
- Delayed Diagnosis of Lung Cancer in Taichung Veterans General Hospital
頁籤選單縮合
題 名 | Successful Surgical Treatment of Solitary Adrenal Metastases from Non-Small Cell Lung Cancer: Case Report=成功以手術治療非小細胞肺癌之腎上腺轉移:病例報告 |
---|---|
作 者 | 饒坤銘; 廖宗琦; 莊正鏗; 李錦輝; | 書刊名 | 長庚醫學 |
卷 期 | 22:2 1999.06[民88.06] |
頁 次 | 頁282-286 |
分類號 | 416.224 |
關鍵詞 | 肺癌; 腎上腺轉移; Lung cancer; Adrenal gland metastasis; |
語 文 | 英文(English) |
中文摘要 | 肺癌在目前全世界的癌症中,其發生率及致死率均為前幾名。手術是N2以下的局 部性肺癌主要的治療方法,但多數肺癌患者在發現肺癌之時或之後不久即發現有遠端轉移, 即使給予化學治療,其平均存大多數仍少於 1 年。 以往均認為肺癌若發生轉移,則不宜再 進行手術切除;但仍有少數病例報告非小細胞肺癌患者,即使發現有單一遠端轉移,對其原 發部位及轉移部位進行積極性的根除治療,如手術、放射治療,患者仍有長期存活的機會。 本篇病例報告即提出一非小細胞肺癌患者,在對其原發部位施以手術切除及局部放射治療後 4 年,才發生腎上腺轉移,而再對此腎上腺轉移施以手術切除,並施予輔助性化學治療後, 此病患至今已存活超過 4 年,且仍無任何復發跡象。 此病患之所以能長期存活,可能是因 為其原發腫瘤比其他同種腫瘤長的得慢的緣故。 |
英文摘要 | Lung cancer is one of the most common types of maligancies and has been one of the leading causes death due to cancer for a long time. Although surgery is the treatment of choice for patients with non-N2 localized disease, most of the lung cancer patients are found to have metastatic lesions at the same time as initial diagnosis. The median survival of patients with metastatic lung cancer is less than one year even when systemic chemotherapy is given. We present a patient with non-small cell lung cancer with no initial evidence of metastasis. He underwent curative resection of the primary tumor followed by local radiotherapy. Adrenal gland metastasis was found fours years after the first surgery. After surgical resection of this metastatic lesion, followed by adjuvant chemotherapy, this patient's survival was prolonged with no evidence of disease recurrence until now. The prolonged survival of this patient may be due to a slow rate of progression of the primary tumor. |
本系統中英文摘要資訊取自各篇刊載內容。